All issues

FDA calendar and trial changes: week to 12 November 2026

Week to 12 Nov 2026: 5 FDA calendar events in the next 60 days, 6 clinical trial record changes on ClinicalTrials.gov. Every item links to its source.

On the FDA calendar, next 60 days

Date as reportedDrug / companyEventEvidence
30 Nov 2026bezuclastinibCogent Biosciences, Inc. (COGT)PDUFA dateGISTOpen original source
22 Dec 2026LorundrostatMineralys Therapeutics Inc. (MLYS)PDUFA datehypertension in combination with other antihypertensive drugsOpen original source
22 Dec 2026LorundrostatMineralys Therapeutics Inc. (MLYS)PDUFA datetreatment of hypertension in combination with other antihypertensive drugsOpen original source
30 Dec 2026bezuclastinibCogent Biosciences, Inc. (COGT)PDUFA dateNonAdvSMOpen original source
30 Dec 2026bezuclastinibCogent Biosciences, Inc. (COGT)PDUFA dateNonAdvSMOpen original source

Open the full FDA calendar

Trial record changes this week

· 4 fields changed

Primary completion date changed

Before: Sep 2026. After: 17 Sep 2026.

Recruitment status changed

Before: Active not recruiting. After: Completed.

Participant count type changed

Before: Estimated. After: Actual.

Completion date type changed

Before: Estimated. After: Actual.

Check registry source

· 5 fields changed

Primary completion date changed

Before: Feb 2026. After: 16 Feb 2026.

Participant count changed

Before: 90 participants (planned). After: 93 participants (actual).

Recruitment status changed

Before: Recruiting. After: Completed.

Participant count type changed

Before: Estimated. After: Actual.

Completion date type changed

Before: Estimated. After: Actual.

Check registry source

Search all tracked trials · Read the latest monthly report